InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Dorenbaum Alejandro, Directeur Médical. Insider active across 1 companies, notably Reneo Pharmaceuticals, Inc.. In total, 2 filings have been recorded. The latest transaction was disclosed on 10 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
030,000 shares0
Common Stock
SEC:0001209191-21-069439·
030,000 shares0
Common Stock
SEC:0001209191-21-069439:0·
2 of 2 declarations
About Dorenbaum Alejandro
Alejandro Dorenbaum is the Chief Medical Officer at Reneo Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. With strong experience in the pharmaceutical sector, he plays a key role in developing new treatments and in Reneo's strategic direction.
